Clinical Study of Jianfei Kangfu Cao in the Treatment of pSS-ILD
NCT ID: NCT04544722
Last Updated: 2021-03-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
138 participants
INTERVENTIONAL
2020-10-01
2023-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Disease-syndrome Characteristics of IPF
NCT07178392
Respiratory Disease Cohort Studies of Chinese Medicine for Pulmonary Nodule
NCT06673121
Fibrotic Interstitial Lung Disease Early Recognition and Strategic Therapy Study in China
NCT06655090
Traditional Chinese Medicine(TCM) Syndrome Classification of Idiopathic Pulmonary Fibrosis(IPF) and Metabolomics
NCT03711435
Efficacy and Safety of Pirfenidone in CTD-ILD
NCT05505409
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Random scheme:the DAS for Interactive Web Response System(IWRS) will be used to calculate and distribute random numbers and dispensing drugs.
2. Blind method ：The test process will be in a double-blind state.
3. Control drug: The lung rehabilitation training will be used as control in this trial.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Jianfei Kangfu Cao
The original treatment and Jianfei Kangfu Cao, once a day, 30 minutes each time.
Jianfei Kangfu Cao
The original treatment and Jianfei Kangfu Cao, once a day, 30 minutes each time.
Lung rehabilitation training
The original treatment and the lung rehabilitation training, once a day, 30 minutes each time.
lung rehabilitation training
The original treatment and the lung rehabilitation training, once a day, 30 minutes each time.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Jianfei Kangfu Cao
The original treatment and Jianfei Kangfu Cao, once a day, 30 minutes each time.
lung rehabilitation training
The original treatment and the lung rehabilitation training, once a day, 30 minutes each time.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. CT confirmed interstitial lung disease;
3. DLCO≧40%;
4. Stable treatment for at least 12 weeks;
5. Patients with good compliance should sign informed consent before the tria.
Exclusion Criteria
2. Pulmonary infection, tumor and other connective tissue diseases;
3. Chronic obstructive pulmonary disease, bronchial asthma and tuberculosis;
4. Patients with severe hypertension, diabetes and heart, liver and renal failure;
5. Women with reproductive needs;
6. Idiopathic pulmonary interstitial disease;
7. The researcher thinks that it is not suitable to participate in this experiment;
8. Participants in other clinical trials.
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai University of Traditional Chinese Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zhujing Zhu, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Longhua Hospital
Jianchun Mao, Master
Role: STUDY_CHAIR
Longhua Hospital
Huanru Qu, Ph.D
Role: STUDY_CHAIR
Longhua Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Jianfei Kangfu Cao
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.